Board of Astrazeneca Pharma India decides to close API unit in Bangalore

Image
Capital Market
Last Updated : Dec 03 2015 | 9:02 PM IST

At meeting held on 02 December 2015

Astrazeneca Pharma India that the Board of Directors of the Company at its meeting held on 02 December 2015 has decided to close the Active Pharmaceutical Ingredient Unit (API Unit) situated at 12th Mile on Bellary Road, Venkatala, Yelahanka, Bangalore - 560063.

Powered by Capital Market - Live News

More From This Section

First Published: Dec 03 2015 | 8:35 PM IST

Next Story